Our result that patients with TNBC were less likely to have had a prior biopsy than patients with hormone receptor-positive disease is consistent with prior studies demonstrating that prior biopsy and/or benign breast disease is associated with estrogen receptor-positive disease and not TNBC [5, 16–19]. The gene discussed is ESR1; the disease is breast fibrocystic disease.